Marion Sewer | |
|---|---|
| Born | October 28, 1972 |
| Died | January 28, 2016 |
| Alma mater | Spelman College, BS in biochemistry (1993); Emory University, PhD in pharmacology; Vanderbilt University, postdoctoral fellow |
| Known for | steroid hormone biosynthesis, lipid metabolism |
| Scientific career | |
| Fields | biochemistry, pharmacology, chemistry |
| Institutions | University of California, San Diego (2009-2016), Georgia Institute of Technology (2002-2008) |
| Doctoral advisor | Edward Morgan |
| Other academic advisors | Michael Waterman |
I have found that biomedical research, particularly in academia, can be isolating, and at times fraught with setbacks and disappointment. In spite of these adversities I think the most important thing that I’ve learned is to not let speed bumps deter you from your goals and to not be afraid to take detours off a set path if these changes move you closer a personally satisfying career.
Marion Sewer[1]
Marion Sewer (1972-2016) was a pharmacologist and professor at the University of California, San Diego's Skaggs School of Pharmacy and Pharmaceutical Sciences known for her research on steroid hormone biogenesis and her commitment to increasing diversity in science. Much of her research centered around cytochrome P450, a family of enzymes involved in the conversion of cholesterol into steroid hormones.[2] She died unexpectedly at the age of 43 from a pulmonary embolism on January 28, 2016, while traveling through the Detroit airport.[3]